Differentiating Severely High Glucose Levels from Hyperosmolar Hyperglycemic State (HHS)
HHS is distinguished from severely high glucose by the presence of extreme hyperglycemia (>600 mg/dL), significant hyperosmolality (>320 mOsm/kg), profound dehydration, altered mental status, and minimal or absent ketosis and acidosis. 1, 2
Key Diagnostic Criteria
Laboratory Parameters
Glucose levels:
- Severely high glucose: >250 mg/dL
- HHS: Typically >600 mg/dL 1
Osmolality:
Acid-base status:
- Severely high glucose: May have normal pH
- HHS: Minimal acidosis (pH >7.3) 1
Ketones:
Clinical Presentation
Time course:
- Severely high glucose: Variable
- HHS: Develops gradually over days to weeks (vs. DKA which develops within hours to a day) 1
Mental status:
Dehydration:
Clinical Assessment Algorithm
Measure blood glucose
- If >600 mg/dL, suspect HHS
Calculate serum osmolality
- Formula: 2[measured Na⁺ (mEq/L)] + glucose (mg/dL)/18
- If >320 mOsm/kg, consistent with HHS
Check for ketones
- Minimal or absent in HHS
- Present in DKA
Assess acid-base status
- HHS: pH typically >7.3, bicarbonate >18 mEq/L
- DKA: pH <7.3, bicarbonate <18 mEq/L
Evaluate mental status
- Significant alteration suggests HHS, especially with extreme hyperglycemia
Common Pitfalls and Caveats
Mixed states can occur: Patients may present with features of both DKA and HHS, particularly those with type 2 diabetes who develop significant stress 1
Age considerations: HHS is more common in elderly patients with type 2 diabetes, while DKA is more common in younger patients with type 1 diabetes, but exceptions occur 1, 5
Precipitating factors: Both conditions share similar precipitating factors (infection, medication non-adherence, new-onset diabetes), but certain medications (glucocorticoids, thiazides, sympathomimetics) are more likely to precipitate HHS 1
Treatment differences:
Mortality risk: HHS has a higher mortality rate (15%) compared to DKA (5%), requiring more intensive monitoring 1
Neurological complications: HHS carries higher risk of seizures, cerebral edema, and central pontine myelinolysis, particularly with rapid osmolality correction 3
By systematically evaluating these parameters, clinicians can accurately differentiate between severely high glucose levels and true HHS, leading to appropriate management strategies and improved patient outcomes.